RFG Advisory’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
4,871
+2,976
+157% +$641K 0.02% 504
2026
Q1
$381K Buy
1,895
+913
+93% +$189K 0.01% 834
2025
Q4
$203K Buy
+982
New +$196K ﹤0.01% 948
2025
Q3
Sell
-1,407
Closed -$227K 970
2025
Q2
$227K Sell
1,407
-554
-28% -$88.3K 0.01% 867
2025
Q1
$334K Buy
1,961
+51
+3% +$8.86K 0.01% 688
2024
Q4
$317K Buy
+1,910
New +$326K 0.01% 633
2023
Q1
Sell
-1,659
Closed -$272K 642
2022
Q4
$272K Sell
1,659
-68
-4% -$10K 0.01% 531
2022
Q3
$254K Sell
1,727
-140
-7% -$19.6K 0.01% 527
2022
Q2
$279K Buy
+1,867
New +$257K 0.02% 476
2021
Q4
Sell
-3,033
Closed -$504K 486
2021
Q3
$504K Buy
3,033
+542
+22% +$92.6K 0.04% 272
2021
Q2
$430K Sell
2,491
-248
-9% -$41K 0.04% 293
2021
Q1
$440K Sell
2,739
-595
-18% -$102K 0.05% 275
2020
Q4
$582K Sell
3,334
-378
-10% -$61.3K 0.08% 218
2020
Q3
$584K Buy
3,712
+327
+10% +$53.5K 0.08% 209
2020
Q2
$568K Sell
3,385
-91
-3% -$14.3K 0.09% 190
2020
Q1
$456K Buy
3,476
+128
+4% +$18.2K 0.09% 193
2019
Q4
$498K Buy
3,348
+193
+6% +$26.5K 0.08% 199
2019
Q3
$390K Buy
3,155
+545
+21% +$72.5K 0.08% 199
2019
Q2
$367K Sell
2,610
-13
-0.5% -$1.79K 0.08% 197
2019
Q1
$397K Sell
2,623
-526
-17% -$75.7K 0.1% 166
2018
Q4
$391K Sell
3,149
-263
-8% -$36K 0.1% 166
2018
Q3
$541K Buy
3,412
+1,163
+52% +$176K 0.14% 147
2018
Q2
$315K Buy
2,249
+312
+16% +$42.8K 0.09% 161
2018
Q1
$257K Sell
1,937
-12
-0.6% -$1.64K 0.1% 162
2017
Q4
$246K Hold
1,949
0.11% 162
2017
Q3
$245K Buy
+1,949
New +$231K 0.15% 134

Other funds holding FBT

RFG Advisory's FBT Position: Q2 2026 in Review

RFG Advisory increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 157% in Q2 2026, buying an estimated $641K and bringing the position to 4,871 shares worth $1.21M. The position accounts for 0.02% of the portfolio, ranked #504.

RFG Advisory first reported a position in FBT in Q3 2017 and has held it in 26 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • RFG Advisory held 4,871 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.21M as of Q2 2026.
  • RFG Advisory bought 2,976 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $641K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of RFG Advisory's portfolio in Q2 2026, its #504 holding.
  • RFG Advisory first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2017 and has held it in 26 quarters since.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.